Ajinomoto Co., Ltd.

Tomio Suda

Kunio Torii

Hisanori Masaki

Masaharu Horiguchi

A composition, comprising L-alanine or a salt thereof, L-glutamine or a salt thereof, and an oligopeptide containing either a L-alanine residue or a L-glutamine residue, or both, is disclosed. A composition made up of (i) L-alanine or a salt thereof, (ii) L-glutamine or a salt thereof, and (iii) an oligopeptide containing a L-alanine or a L-glutamine residue is also discloed. The L-alanine and the L-glutamine are present in these compositions in an available molar ratio of from 1:0.1 to 1:10, respectively. These compositions are useful in the therapy or prevention of hepatic disorders.

Compositions useful for the treatment and/or prevention of hepatic

A pharmaceutical composition for preventing or alleviating the effects of acute alcoholism, in particular liver disturbances in mammals, which comprises a mixture of alanine or a pharmaceutically acceptable salt or derivative thereof capable of effectively acting as alanine in vivo or a mixture thereof, and ornithine or a pharmaceutically acceptable salt or derivative thereof capable of effectively acting as ornithine in vivo or a mixture thereof in a ratio such that the amount of ornithine present in said mixture is at least about 1/1000 the amount of alanine present, both of said ornithine and alanine being present in an amount effective to prevent or alleviate said effects.

Growing community of inventors

Tachidawa, Japan

Tomio Suda